IART Integra Lifesciences Holdings PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: IART
- PE Ratio
The current P/E ratio of IART cannot be calculated, as the latest EPS of -$6.46 is negative. The most recent PE ratio recorded for Integra Lifesciences Holdings was 97.13 in June 2024.
IART PE ratio history
Over the last ten years, the average PE ratio of Integra Lifesciences Holdings has been 93.86. Analyzing the last ten years, IART's PE ratio reached its highest point in the Mar 2016 quarter at 1,122.67, with a price of $33.68 and an EPS of $0.03. The Sep 2022 quarter saw the lowest point at 20.46, with a price of $42.36 and an EPS of $2.07.
Integra Lifesciences Holdings PE ratio by year
Maximum annual increase: 99.22% in 2023
Maximum annual decrease: -58.4% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $22.68 | -$0.09 |
| 2023 | 51.24 | 99.22% | $43.55 | $0.85 |
| 2022 | 25.72 | -23.22% | $56.07 | $2.18 |
| 2021 | 33.5 | -18.47% | $66.99 | $2 |
| 2020 | 41.09 | -58.4% | $64.92 | $1.58 |
| 2019 | 98.78 | 59.89% | $58.28 | $0.59 |
| 2018 | 61.78 | 8.42% | $45.1 | $0.73 |
| 2017 | 56.98 | 32.82% | $47.86 | $0.84 |
| 2016 | 42.9 | N/A | $42.9 | $1 |
| 2015 | N/A | N/A | $33.89 | -$0.05 |
| 2014 | 52.14 | N/A | $27.12 | $0.52 |
| 2013 | N/A | N/A | $23.86 | -$0.37 |
| 2012 | 26.69 | -15.16% | $19.49 | $0.73 |
| 2011 | 31.46 | 46.33% | $15.42 | $0.49 |
| 2010 | 21.5 | 2.63% | $23.65 | $1.1 |
Integra Lifesciences Holdings PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2025 | N/A | N/A | $14.33 | -$6.46 |
| Jun 2025 | N/A | N/A | $12.27 | -$6.53 |
| Mar 2025 | N/A | N/A | $21.99 | -$0.38 |
| Dec 2024 | N/A | N/A | $22.68 | -$0.09 |
| Sep 2024 | N/A | N/A | $18.17 | -$0.08 |
| Jun 2024 | 97.13 | 39.74% | $29.14 | $0.3 |
| Mar 2024 | 69.51 | 35.66% | $35.45 | $0.51 |
| Dec 2023 | 51.24 | 65.02% | $43.55 | $0.85 |
| Sep 2023 | 31.05 | 20.02% | $38.19 | $1.23 |
| Jun 2023 | 25.87 | -6.27% | $41.13 | $1.59 |
| Mar 2023 | 27.6 | 7.31% | $57.41 | $2.08 |
| Dec 2022 | 25.72 | 25.71% | $56.07 | $2.18 |
| Sep 2022 | 20.46 | -25.03% | $42.36 | $2.07 |
| Jun 2022 | 27.29 | -21.45% | $54.03 | $1.98 |
| Mar 2022 | 34.74 | 3.7% | $64.26 | $1.85 |
IART Price vs fair value
IART average PE ratio chart
PE comparison
IART PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| CNMD CONMED Corp | 12.48 | $1.38B |
| JNJ Johnson & Johnson | 17.89 | $449.57B |
| MDT Medtronic plc | 24.8 | $115.79B |
| TFX Teleflex Inc | 28.81 | $5.51B |
| CAH Cardinal Health Inc | 29.55 | $46.76B |
| SYK Stryker Corp | 46.33 | $136.78B |
| XRAY DENTSPLY SIRONA Inc | N/A | $2.12B |
| IART Integra Lifesciences Holdings Corp | N/A | $887.97M |
Frequently asked questions
What is Integra Lifesciences Holdings's PE ratio?
The current price to earnings ratio of IART cannot be determined, as its EPS of -$6.46 is negative.
What is the 3-year average PE ratio for Integra Lifesciences Holdings (IART)?
Over the last 3 years, the average PE ratio for IART stock is 46.87.
What is the 5-year average PE ratio for Integra Lifesciences Holdings (IART)?
Over the last 5 years, the average PE ratio for IART stock is 38.31.
What is the highest PE ratio for IART?
Over the last ten years, the quarterly PE ratio reached its highest level at 1,122.67 in the Mar 2016 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.